Compare CMPX & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | CPAC |
|---|---|---|
| Founded | 2014 | 1949 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 848.5M |
| IPO Year | 2020 | 2003 |
| Metric | CMPX | CPAC |
|---|---|---|
| Price | $2.42 | $10.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $14.57 | $12.90 |
| AVG Volume (30 Days) | ★ 6.0M | 16.7K |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 5.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.49 |
| Revenue Next Year | $934.41 | N/A |
| P/E Ratio | ★ N/A | $19.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.61 | $5.66 |
| 52 Week High | $6.88 | $11.50 |
| Indicator | CMPX | CPAC |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 45.59 |
| Support Level | $1.68 | $10.32 |
| Resistance Level | $3.82 | $10.88 |
| Average True Range (ATR) | 0.17 | 0.20 |
| MACD | 0.19 | -0.02 |
| Stochastic Oscillator | 92.35 | 26.32 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.